Skip to main content

Allergies News (Page 5)

Related terms: Allergy, Dust Mite Allergy

Dr. Jeanne Marrazzo Will Replace Fauci to Lead National Institute of Allergy and Infectious Diseases

WEDNESDAY, Aug. 2, 2023 – Dr. Jeanne Marrazzo was named on Wednesday to become the next head of the U.S. National Institute of Allergy and Infectious Diseases, a job most recently held by Dr....

Even Transient Food Allergy in Infancy Impacts Later Lung Function

WEDNESDAY, Aug. 2, 2023 – Food allergy in infancy, whether it resolves or not, is associated with lung function deficits and asthma at age 6 years, according to a study published online July 25 in...

New Clues to Treating a Disease That Prevents Children From Swallowing, Eating

TUESDAY, Aug. 1, 2023 – Children who have a chronic immune system disease that can prevent them from eating may eventually have a new treatment, decades after the condition was first identified....

Researchers Use EHR Systems to ID Pediatric Allergy Patterns

TUESDAY, Aug. 1, 2023 – In a study published online July 25 in Pediatrics, the authors describe pediatric allergy patterns across the United States. Stanislaw J. Gabryszewski, M.D., Ph.D., from the...

More Parents Are Introducing Peanuts Early

MONDAY, July 31, 2023 – Early peanut feeding practices are gaining traction among U.S. parents/caregivers, according to a study published online July 21 in Pediatrics. Waheeda Samady, M.D., from the...

Nearly a Half-Million Americans Might Have Tick-Borne Meat Allergy Syndrome

THURSDAY, July 27, 2023 – Tick bites can cause crippling infections like Lyme disease in humans, but new research suggests they can also trigger a serious meat allergy in far more Americans than...

Milk Alternatives Don't Always Measure Up to Milk

TUESDAY, July 25, 2023 – If you’re drinking soy, oat or almond milk, you may not be getting the same nutrients as you would with a glass of cow’s milk. A new analysis of more than 200 plant-based mil...

Direct Oral Penicillin Challenge Noninferior to Standard of Care

TUESDAY, July 25, 2023 – For patients with low-risk penicillin allergy, direct oral penicillin challenge is noninferior to standard-of-care skin testing followed by oral challenge, according to a...

U.S. FDA Approves ALK's Odactra (House Dust Mite Allergen Extract) Tablet for Sublingual Use as Immunotherapy for Adolescents

Odactra is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in persons 12 through 17 years of age, in addition to adults 18 through 65 years of...

FDA Medwatch Alert: FDA Alerts Patients and Health Care Professionals that Some EpiPen Auto-Injectors May Not Readily Slide Out of Carrier Tube

[11/2/2018] FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions,...

Adamis Pharmaceuticals Receives FDA Approval for Its Lower Dose Symjepi Product

SAN DIEGO, Sept. 27, 2018 (GLOBE NEWSWIRE) – Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) (“Adamis”) today announced that the U.S. Food and Drug Administration (“FDA”) has approved Adamis’ lower...

FDA Approves Odactra for House Dust Mite Allergies

March 1, 2017 – The U.S. Food and Drug Administration today approved Odactra, the first allergen extract to be administered under the tongue (sublingually) to treat house dust mite (HDM)-induced...

Sanofi's Xyzal Allergy 24HR Approved for Over-the-Counter Use

BRIDGEWATER, N.J., Feb. 1, 2017 /PRNewswire/ – Sanofi announced today that the U.S. Food and Drug Administration (FDA) approved Xyzal Allergy 24HR as an over-the-counter (OTC) treatment for the...

FDA Approves Flonase Sensimist Allergy Relief

WARREN, N.J. 2 August 2016 – GSK Consumer Healthcare announced today that the U.S. Food and Drug Administration (FDA) has approved Flonase® Sensimist™ Allergy Relief (fluticasone furoate, 27.5 mcg sp...

FDA Medwatch Alert: Auvi-Q (epinephrine injection, USP): Recall - Potential Inaccurate Dosage Delivery

ISSUE: Sanofi US is voluntarily recalling all Auvi-Q (epinephrine injection, USP). The recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.3 mg strengths for...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Hay Fever, Allergic Rhinitis, Allergic Reactions

Related drug support groups

prednisone, Benadryl, hydroxyzine, methylprednisolone, triamcinolone, Zyrtec, diphenhydramine, Allegra, loratadine, view more... promethazine, cetirizine, prednisolone, Vistaril, Phenergan, phenylephrine, pseudoephedrine, dexamethasone, Atarax, montelukast, fexofenadine, desonide, cyproheptadine, epinephrine